Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic equivalence study of OsvaRen tablets versus OsvaRen granules
2012-004178-24Phase 3Completed
- Sponsor
- Fresenius Medical Care
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of calcium acetate + magnesium carbonate in hyperphosphatemia, end-stage kidney disease (ESKD), sponsored by Fresenius Medical Care. Started Oct 2013; status: completed.
02
Drugs
calcium acetate + magnesium carbonate
03
Conditions
hyperphosphatemiaend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2012-004178-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004178-24.